Glenn M. Chertow

TL;DR: Assuming that the benefits of tolvaptan persist in the longer term, the drug may slow progression to ESRD and reduce mortality rates, however, barring an approximately 95% reduction in price, cost-effectiveness does not compare favorably with many other commonly accepted medical interventions.

TL;DR: Higher fetuin-A concentrations are associated with the accumulation of VAT in well-functioning, community-living older persons, and the mechanisms linking fetulin-A, VAT, and insulin resistance remain to be determined.

TL;DR: In this article, the authors compared three-times weekly treatment to more frequent treatment with a longer weekly treatment time in patients receiving in-center hemodialysis and found that increased treatment frequency and time resulted in an average reduction of only 15 percent in the levels of 107 uremic solutes.

TL;DR: Single processes of care and complications are associated with AVF maturation outcomes and unassisted and overall clinical maturation as defined by the HFM Study criteria is more likely.

TL;DR: Investigating the beneficial effects of fixed-dose ferric citrate coordination complex on biochemical parameters, as well as the exploratory results regarding the composite end point and hospitalization, suggest that fixed- dose ferriccitrate coordinationcomplex has an excellent safety profile in an unselected population with advanced CKD and merits further study.